0R31 Stock Chart & Stats
$72.98
$0.08(0.11%)
At close: 4:00 PM EDT
$72.98
$0.08(0.11%)
Day’s Range― - ―
52-Week Range$54.50 - $77.01
Previous CloseN/A
Volume2.63K
Average Volume (3M)12.49K
Market Cap
$112.99B
Enterprise Value$142.42K
Total Cash (Recent Filing)$2.37B
Total Debt (Recent Filing)$24.58B
Price to Earnings (P/E)14.5
Beta0.37
Next Earnings
Oct 29, 2026EPS Estimate
1.51Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)4.74
Shares Outstanding1,669,743,900
10 Day Avg. Volume3,110
30 Day Avg. Volume12,494
Financial Highlights & Ratios
PEG Ratio-0.38
Price to Book (P/B)-27.61
Price to Sales (P/S)4.80
P/FCF Ratio10.66
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$71.63Price Target Upside-1.86% Downside
Rating ConsensusModerate Buy
Number of Analyst Covering10
EPS Forecast (FY)5.69
Revenue Forecast (FY)$20.55B
Bulls Say, Bears Say
Bulls Say
Strong Profitability And Pricing PowerVery high operating margins and positive price realization show Altria can offset declining cigarette volumes through premium brands, pricing and cost control. This supports durable earnings resilience, although annual margin variability limits predictability.
Robust Cash GenerationCash conversion closely tracks reported earnings, providing resources for dividends, investment and debt servicing. This strengthens financial durability and supports capital allocation, though modestly declining free cash flow could reduce flexibility if sustained.
Smoke-Free Product ExpansionBroader distribution and rising pouch share give Altria a scalable growth avenue beyond combustibles. Repeat purchases and expanding availability can strengthen its smoke-free position, while regulatory enforcement may improve the environment for compliant products.
Bears Say
Highly Levered Balance SheetHigh debt combined with negative equity leaves a thin accounting capital cushion and limits financial flexibility. Although current cash generation supports obligations, any prolonged earnings or free-cash-flow decline could constrain investment and increase refinancing sensitivity.
Secular Cigarette Volume DeclinesPersistent category contraction erodes the core profit pool, while consumer trade-down pressures premium mix and Marlboro share. Pricing can offset volume losses for a time, but sustained declines raise the long-term burden on smokeable earnings.
Oral Tobacco Profitability PressureWeak oral segment profit and volume performance shows that growth investments in on! PLUS are currently dilutive rather than fully productive. Promotional spending, difficult comparisons and execution risk could delay the category’s contribution to earnings.
Altria Group News
0R31 FAQ
What was Altria’s price range in the past 12 months?
Altria lowest share price was $54.50 and its highest was $77.01 in the past 12 months.
What is Altria’s market cap?
Altria’s market cap is $112.99B.
When is Altria’s upcoming earnings report date?
Altria’s upcoming earnings report date is Oct 29, 2026 which is in 61 days.
How were Altria’s earnings last quarter?
Altria released its earnings results on Jul 30, 2026. The company reported $1.48 earnings per share for the quarter, missing the consensus estimate of $1.496 by -$0.016.
Is Altria overvalued?
According to Wall Street analysts Altria’s price is currently Overvalued.
Does Altria pay dividends?
Altria does not currently pay dividends.
What is Altria’s EPS estimate?
Altria’s EPS estimate is 1.51.
How many shares outstanding does Altria have?
Altria has 1,669,743,900 shares outstanding.
What happened to Altria’s price movement after its last earnings report?
Altria reported an EPS of $1.48 in its last earnings report, missing expectations of $1.496. Following the earnings report the stock price went down -9.209%.
Which hedge fund is a major shareholder of Altria?
Currently, no hedge funds are holding shares in GB:0R31
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Altria Group Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$71.63 (-1.86% Downside)
$71.63 (-1.86% Downside)
Blogger Sentiment
Bullish
GB:0R31 Sentiment 61%
Sector Average ―
Sector Average ―
News Sentiment
Bullish
Bullish news 67%
Bearish news 33%
Bearish news 33%
Technicals
SMA
Positive
20 days / 200 days
Momentum
30.75%
12-Months-Change
Fundamentals
Return on Equity
6.22%
Trailing 12-Months
Asset Growth
3.22%
Trailing 12-Months
Company Description
Altria
Operating across the United States through its subsidiaries, Altria Group, Inc. is a prominent manufacturer and marketer of both combustible and oral tobacco items. Its portfolio features cigarettes, primarily under the iconic Marlboro brand, alongside cigars and pipe tobacco mainly offered as Black & Mild. The enterprise further provides an assortment of moist smokeless tobacco products, including Copenhagen, Skoal, Red Seal, and Husky, in addition to its on! brand of oral nicotine pouches. Altria distributes its merchandise chiefly to wholesale partners, such as independent distributors, and directly to substantial retail organizations, including major chain stores. The corporation, founded in 1822, maintains its principal offices in Richmond, Virginia.
0R31 Company Deck
0R31 Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call emphasized solid financial performance and disciplined execution: EPS growth (Q2 +2.8%, H1 +4.9%), expanded smokeable margins, a narrowed full-year EPS range, substantial shareholder returns (~$3.9 billion YTD), ABI earnings growth (+21.5%), and strategic expansion of the smoke-free on! PLUS offering to ~120,000 stores. Offsetting items included a weaker Oral Tobacco quarter (adjusted OCI down 8% Q2), reported shipment declines affected by trade inventory timing, ongoing cigarette volume declines (adjusted ~-4.5% Q2) and continued consumer trade-down toward discount brands. Management highlighted favorable regulatory and enforcement developments that could benefit regulated smoke-free products over time. On balance, the positives around profitability, cash returns, regulatory tailwinds and product expansion were presented as outweighing near-term volume and segment-specific headwinds.View all GB:0R31 earnings summaries0R31 Revenue Breakdown
88.00% Smokeable products
12.04% Oral tobacco products
-0.06% E-vapor products
0.02% All other
0R31 Stock 12 Month Forecast
Average Price Target
$71.63
▼(-1.86% Downside)
Technical Analysis
British American Tobacco
―
Philip Morris
―
22nd Century
―
Turning Point Brands
―
RLX Technology
―